Statements of Cash Flows - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,613,068)	$ (2,311,233)
Adjustments to reconcile net loss to net cash used in operating activities
Preferred shares issued as compensation	32,890	53,098
Preferred shares issued pursuant to license agreement	935,088	0
Common shares issued as compensation and for services	42,000	38,250
Warrants granted to Scientific Advisory Board	1,352	1,986
Amortization of loan origination fees	0	9,825
Depreciation	174,357	175,162
Amortization	2,067	2,067
Changes in operating assets and liabilities:
Prepaid expenses	111,423	44,257
Other assets	0	3,910
Accounts payable	(83,768)	(122,560)
Accounts payable - related party	673,638	(123,762)
Accrued expenses	(210)	(6,945)
NET CASH USED IN OPERATING ACTIVITIES	(724,231)	(2,235,945)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(24,313)	(34,985)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from issuance of common stock and warrants	0	10,442,216
Deferred financing costs	0	(41,024)
Payment of loan payable	(71,339)	(47,034)
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES	(71,339)	10,354,158
NET CHANGE IN CASH AND CASH EQUIVALENTS	(819,883)	8,083,228
Cash and cash equivalents at beginning of period	20,516,677	13,708,594
Cash and cash equivalents at end of period	19,696,794	21,791,822
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Interest paid	892	589
Income tax paid	$ 0	$ 0